For those not familiar with the industry dynamics/vernacular, let me explain what the 🐑 is saying here about current selling pressure. The market-neutral/pod world These are multi-strategy firms that split their money among lots of small teams (“pods”). Many of those teams try to stay market-neutral: they own some stocks and short others in roughly equal size so they’re not just betting that the whole market goes up. They live and die by risk limits. When volatility jumps or their models say a sector is too risky, they cut positions fast - often all at once. Because they use a lot of leverage, even a modest risk reduction can mean a lot of selling. Sector specialist SMAs These are separately managed accounts (private portfolios run for one big client), in this case for biotech. The manager isn’t running a big shared fund; they’re running a custom account for that one client. That setup can be convenient for the client, but it also makes the money less “sticky.” If the client gets nervous, or a lender looking at the account tightens the screws, the manager can be forced to sell quickly. When a bunch of these specialist accounts de-risk at the same time, you get a wave of selling in the same names. In short; this looks more like a mechanical, risk-management selloff from those two groups than a fundamental story.